Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/20256
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorBravo Muñoz, Karent Elizabeth-
dc.contributor.authorPereañez Jiménez, Jaime Andrés-
dc.date.accessioned2021-06-23T00:26:32Z-
dc.date.available2021-06-23T00:26:32Z-
dc.date.issued2016-
dc.identifier.issn0121-4004-
dc.identifier.urihttp://hdl.handle.net/10495/20256-
dc.description.abstractABSTRACT: Colombia, a country privileged by nature, where diversity of climates are created by large altitude gradients which generate a variety of ecosystems and beautiful badlands, punas, mountain forests, dry valleys, high deserts and salt flats; landscapes that have diversity of plants and animals and we are cata- loged as one of the countries as the greatest diversity in the world, preceded by Brazil and followed by Indonesia, China and Mexico. We have 28.000 plants and lichens; it is an invaluable heritage that can give to our country competitive advantages in the discovery and development of active ingredients for the pharmaceutical and cosmetic industry by sustainable use of our biodiversity.spa
dc.format.extent3spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherUniversidad de Antioquia, Facultad de Ciencias Farmacéuticas y Alimentariasspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/2.5/co/*
dc.titleColombian Biodiversity, an Opportunity for the Strengthening of the Pharmaceutical and Cosmetic Industriesspa
dc.title.alternativeLa biodiversidad colombiana, una oportunidad para el fortalecimiento de las Industrias farmacéutica y cosméticaspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Investigación en Sustancias Bioactivas (GISB)spa
dc.publisher.groupToxinología Alternativas Terapéuticas y Alimentariasspa
dc.identifier.doi10.17533/udea.vitae.v23n3a01-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2145-2660-
oaire.citationtitleVitaespa
oaire.citationstartpage163spa
oaire.citationendpage165spa
oaire.citationvolume23spa
oaire.citationissue3spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.publisher.placeMedellín, Colombiaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_b239spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTEDITspa
dc.type.localEditorialspa
dc.subject.decsPreparaciones Farmacéuticas-
dc.subject.decsPharmaceutical Preparations-
dc.subject.decsBiodiversidad-
dc.subject.decsBiodiversity-
dc.subject.lembProductos naturales-
dc.subject.lembNatural products-
dc.description.researchgroupidCOL0014476spa
dc.description.researchgroupidCOL0010359spa
dc.relation.ispartofjournalabbrevVitaespa
Aparece en las colecciones: Editorial y Carta al Editor en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
BravoKarent_2016_ColombianBiodiversityStrengthening.pdfEditorial121.95 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons